Clinical Trial Update: Pharmacokinetics Study of Mycophenolic Acid in Patients With an Autoimmune Bullous Dermatose, Pemphigus or Cicatricial Pemphigoid. [Phase 3]

View source ↗

Summary

Phase 3 pharmacokinetics study of mycophenolic acid in patients with autoimmune bullous skin diseases (pemphigus and cicatricial pemphigoid) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Bullous Dermatitis
• Cicatricial Pemphigoid
• Pemphigus

Drugs mentioned

• Mycophenolic acid (mycophenolic acid)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Autoimmune Bullous Dermatose | Phase 3 | Status: COMPLETED